Code 3®, Inc., a leading manufacturer and developer of light and sound emergency products, today announced the launch of its new germ killing Patient Compartment Light Powered by Vital Vio.
Code 3’s Patient Compartment Light powered by Vital Vio’s VioSafe™ White Light Disinfection™ Technology multi-tasks by providing continuous disinfection of bacteria on objects and surfaces, while providing safe illumination with its precisely engineered wavelengths of visible light. Vital Vio’s lighting technology is proven effective in killing bacteria and other harmful organisms including: MRSA, Salmonella, E. coli, and C. diff.
Duke has found a new, innovative piece of tech to protect its athletes. The school announced a partnership with Vital Vio, a company using LED light to kill bacteria and stop the spread of infection. [Read More]
Vital Vio has entered into a licensing agreement with Acuity Brands, Inc. (NYSE: AYI), one of the world’s leading providers of lighting and building management solutions. Acuity Brands will incorporate our VioSafe™ White Light Disinfection™ technology into certain of its LED luminaires, beginning with health care applications.
Troy, NY (April 20, 2017) – VioSafe™ White Light Disinfection™ technology, designed by Vital Vio to safely and continuously kill germs on indoor surfaces, has been selected as the 2017 Gold Award winner in the Healthy Lighting category, by the internationally renowned Edison Awards™. The distinguished awards, inspired by Thomas Edison’s persistence and inventiveness, recognize innovation, creativity and ingenuity in the global economy.
Continue reading “Vital Vio’s White Light Continuous Disinfection™ Technology Earns Prestigious Edison Award Gold Ranking in “Healthy Lighting” Category”
South Bend, Indiana, April 2017 – VidaShield™, an innovator in fast, continuous air purification technology, and Vital Vio™, the company reinventing disinfection, have announced a strategic partnership to address the healthcare community’s need for technological solutions to reduce bacteria, fungi, germs and odors. This partnership will allow healthcare facilities to leverage the latest technology to dramatically reduce their bioburden and infection risk.
Describing Vital Vio’s disinfecting technology and outlining key advances during the last year – including innovations that enabled the breakthrough of incorporating the disinfection capacity into a single-diode LED, while doubling the efficiency of their disinfection technology – Colleen Costello got the attention of the audience at the Investors Forum, of the 2017 Strategies In Light + The Led Show & Expo.
Continue reading “A Top Idea at Strategies in Light”
Vital Vio President to Speak at Strategies In Light LED Conference February 28, 2017
Troy, NY (February 28, 2017) – VioSafe™ White Light Disinfection™ technology, designed by Vital Vio to safely and continuously kill germs on indoor surfaces, has been named a 2017 Award Finalist in the Healthy Lighting category, by the internationally renowned Edison Awards™. The distinguished awards, inspired by Thomas Edison’s persistence and inventiveness, recognize innovation, creativity and ingenuity in the global economy. Continue reading “Vital Vio’s White Light Continuous Disinfection Technology Named Edison Awards “Healthy Lighting” Finalist”
The National Association of Corporate Directors (NACD), the standard setter for board leadership, recently awarded each of three emerging companies—BoostUp, Vital Vio, and Disease Diagnostic Group—a $30,000 prize package at its first start-up pitch competition. The competition, “Dancing With the Start-Ups,” was a fast-paced, Shark Tank-style challenge where 12 start-ups from the health, energy, and financial services sectors had four minutes to sell their companies to a panel of expert judges and an audience of corporate directors.
Colleen Costello – Forbes & Inc. 30 Under 30 and President & Co-Founder at Vital Vio
Colleen Costello’s career spans clinical & healthcare research, engineering, biochemistry, product development, management practices and opportunity analysis. She has held positions as a researcher on master thesis projects at Mount Sinai School of Medicine and Weill Cornell Medical College, NYC, in surgical device design and pre-clinical studies at Covidien Surgical Devices, and tissue engineering research at RPI. Colleen has several patents pending and holds a degree in Biomedical Engineering with a minor in Technological Entrepreneurship from Rensselaer Polytechnic Institute. She has additionally been featured on CNBC, and Bloomberg News, was named a 50 Emerging Global Entrepreneur to Watch by Inc. Magazine, was an Albany Business Review 40 Under 40 winner and is a selected member of the Kairos Society. Colleen was named both a Forbes & Inc. 30 Under 30 winner!